Sign In
About Santen
Skip Navigation LinksSanten > Ireland > About Santen > Santen in Europe
Santen Pharmaceutical welcomes your enquiries and opinions

Santen in Europe

During the last decade, Santen has strengthened its presence in Europe to become an important player in the field of ophthalmology.


Santen is one of the few international companies that specialise primarily in ophthalmology. At present, Santen is working with key university research centers and European key opinion leaders to better understand the pathology and disease in this area. Ultimately their work will be used to help facilitate diagnosis and management of this condition.


Santen is committed to protecting and improving vision, especially in ophthalmic disorders requiring new treatment approaches.


Key figures about Santen Europe​

  • In existence for 20 years 
    • 1994: Germany
    • 1997: Finland & Scandinavia (acquisition of Oy Star AB)
    • ​2011: France (acquisition of Novagali Pharma)
  • Presence in 20 countries with over 550 employees 
  • 2 R&D Centres: Tampere & Novagali Innovation Centre (NIC)
  • 1 manufacturing site: Tampere
  • Products exported to Europe, MENA and USA